Lyell Immunopharma Inc (LYEL)
1.31
-0.73
(-35.78%)
USD |
NASDAQ |
Jun 26, 15:14
Lyell Immunopharma Shares Outstanding: 254.94M for May 2, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
May 02, 2024 | 254.94M |
April 16, 2024 | 254.94M |
March 31, 2024 | 254.93M |
February 22, 2024 | 254.10M |
December 31, 2023 | 253.96M |
November 02, 2023 | 251.87M |
September 30, 2023 | 251.87M |
August 03, 2023 | 251.03M |
June 30, 2023 | 251.03M |
April 28, 2023 | 249.61M |
April 18, 2023 | 249.61M |
March 31, 2023 | 249.61M |
February 24, 2023 | 249.61M |
December 31, 2022 | 249.57M |
November 03, 2022 | 249.33M |
Date | Value |
---|---|
September 30, 2022 | 249.24M |
August 01, 2022 | 247.83M |
June 30, 2022 | 247.11M |
May 05, 2022 | 246.14M |
April 12, 2022 | 247.11M |
March 31, 2022 | 245.42M |
March 25, 2022 | 245.39M |
December 31, 2021 | 242.74M |
November 05, 2021 | 240.47M |
September 30, 2021 | 239.79M |
August 09, 2021 | 239.40M |
June 30, 2021 | 238.55M |
June 17, 2021 | 242.83M |
June 09, 2021 | 242.83M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
238.55M
Minimum
Jun 30 2021
254.94M
Maximum
May 02 2024
247.96M
Average
249.33M
Median
Nov 03 2022
Shares Outstanding Benchmarks
GlycoMimetics Inc | 64.46M |
Candel Therapeutics Inc | 29.74M |
Eliem Therapeutics Inc | 29.09M |
Entrada Therapeutics Inc | 33.76M |
NovaBay Pharmaceuticals Inc | 1.081M |